Description
Traumatic brain injury (TBI) is a multifaceted disorder induced by an external mechanical force to the brain. It is a leading cause of death and disability worldwide, and there are no treatments to improve long-term recovery. Psilocybin is a psychedelic prodrug and 5-HT2A receptor agonist that effectively promotes neurite growth and synapse formation. This project will involve immunohistochemical analysis of brain samples which were obtained from rats that had undergone a TBI alongside treatment with psilocybin. The purpose of this project will be to assess whether psilocybin is capable of restoring any immunohistochemical changes observed following TBI.
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
TBI, Psilocybin
School
School of Translational Medicine » Neuroscience
Available options
Honours
BMedSc(Hons)
Time commitment
Full-time
Physical location
Alfred Centre
Co-supervisors
Dr
Joshua Allen
(External)